COMT Val158met genotype and striatal D2/3 receptor binding in adults with 22q11 deletion syndrome

17Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Although catechol-O-methyltransferase (COMT) activity evidently affects dopamine function in prefrontal cortex, the contribution is assumed less significant in striatum. We studied whether a functional polymorphism in the COMT gene (Val158Met) influences striatal D2/3R binding ratios (D2/3R BPND) in 15 adults with 22q11 deletion syndrome and hemizygous for this gene, using single photon emission computed tomography and the selective D2/3 radioligand [123I]IBZM. Met hemizygotes had significantly lower mean D2/3R BPND than Val hemizygotes. These preliminary data suggest that low COMT activity may affect dopamine levels in striatum in humans and this may have implications for understanding the contribution of COMT activity to psychiatric disorders. © 2011 Wiley-Liss, Inc..

Cite

CITATION STYLE

APA

Boot, E., Booij, J., Zinkstok, J. R., Baas, F., Swillen, A., Owen, M. J., … Van Amelsvoort, T. A. (2011). COMT Val158met genotype and striatal D2/3 receptor binding in adults with 22q11 deletion syndrome. Synapse, 65(9), 967–970. https://doi.org/10.1002/syn.20932

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free